These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15991018)

  • 1. A simplified analysis of [18F]3'-deoxy-3'-fluorothymidine metabolism and retention.
    Shields AF; Briston DA; Chandupatla S; Douglas KA; Lawhorn-Crews J; Collins JM; Mangner TJ; Heilbrun LK; Muzik O
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1269-75. PubMed ID: 15991018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer.
    Muzi M; Vesselle H; Grierson JR; Mankoff DA; Schmidt RA; Peterson L; Wells JM; Krohn KA
    J Nucl Med; 2005 Feb; 46(2):274-82. PubMed ID: 15695787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies.
    Muzi M; Mankoff DA; Grierson JR; Wells JM; Vesselle H; Krohn KA
    J Nucl Med; 2005 Feb; 46(2):371-80. PubMed ID: 15695799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic modeling of 3'-deoxy-3'-18F-fluorothymidine for quantitative cell proliferation imaging in subcutaneous tumor models in mice.
    Kim SJ; Lee JS; Im KC; Kim SY; Park SA; Lee SJ; Oh SJ; Lee DS; Moon DH
    J Nucl Med; 2008 Dec; 49(12):2057-66. PubMed ID: 18997037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas.
    Muzi M; Spence AM; O'Sullivan F; Mankoff DA; Wells JM; Grierson JR; Link JM; Krohn KA
    J Nucl Med; 2006 Oct; 47(10):1612-21. PubMed ID: 17015896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of methodologies for the in vivo assessment of 18FLT utilisation in colorectal cancer.
    Visvikis D; Francis D; Mulligan R; Costa DC; Croasdale I; Luthra SK; Taylor I; Ell PJ
    Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):169-78. PubMed ID: 15129698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-fluorothymidine kinetics of malignant brain tumors.
    Schiepers C; Chen W; Dahlbom M; Cloughesy T; Hoh CK; Huang SC
    Eur J Nucl Med Mol Imaging; 2007 Jul; 34(7):1003-11. PubMed ID: 17295039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-Fluorothymidine radiation dosimetry in human PET imaging studies.
    Vesselle H; Grierson J; Peterson LM; Muzi M; Mankoff DA; Krohn KA
    J Nucl Med; 2003 Sep; 44(9):1482-8. PubMed ID: 12960196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic analysis of 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) in head and neck cancer patients before and early after initiation of chemoradiation therapy.
    Menda Y; Boles Ponto LL; Dornfeld KJ; Tewson TJ; Watkins GL; Schultz MK; Sunderland JJ; Graham MM; Buatti JM
    J Nucl Med; 2009 Jul; 50(7):1028-35. PubMed ID: 19525472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods.
    Kenny LM; Vigushin DM; Al-Nahhas A; Osman S; Luthra SK; Shousha S; Coombes RC; Aboagye EO
    Cancer Res; 2005 Nov; 65(21):10104-12. PubMed ID: 16267037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis and reproducibility of 3'-Deoxy-3'-[18F]fluorothymidine positron emission tomography imaging in patients with non-small cell lung cancer.
    Shields AF; Lawhorn-Crews JM; Briston DA; Zalzala S; Gadgeel S; Douglas KA; Mangner TJ; Heilbrun LK; Muzik O
    Clin Cancer Res; 2008 Jul; 14(14):4463-8. PubMed ID: 18628460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.
    Barthel H; Cleij MC; Collingridge DR; Hutchinson OC; Osman S; He Q; Luthra SK; Brady F; Price PM; Aboagye EO
    Cancer Res; 2003 Jul; 63(13):3791-8. PubMed ID: 12839975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The uptake of 3'-deoxy-3'-[18F]fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levels.
    Barthel H; Perumal M; Latigo J; He Q; Brady F; Luthra SK; Price PM; Aboagye EO
    Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):257-63. PubMed ID: 15791434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of simplified methods to measure 18F-FLT uptake changes in EGFR-mutated non-small cell lung cancer patients undergoing EGFR tyrosine kinase inhibitor treatment.
    Frings V; Yaqub M; Hoyng LL; Golla SS; Windhorst AD; Schuit RC; Lammertsma AA; Hoekstra OS; Smit EF; Boellaard R;
    J Nucl Med; 2014 Sep; 55(9):1417-23. PubMed ID: 24970910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of PET imaging with the proliferation marker [18F]-FLT.
    Peck M; Pollack HA; Friesen A; Muzi M; Shoner SC; Shankland EG; Fink JR; Armstrong JO; Link JM; Krohn KA
    Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):95-104. PubMed ID: 25737423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of 3'-deoxy-3'-18F-fluorothymidine during treatment monitoring of recurrent high-grade glioma.
    Schiepers C; Dahlbom M; Chen W; Cloughesy T; Czernin J; Phelps ME; Huang SC
    J Nucl Med; 2010 May; 51(5):720-7. PubMed ID: 20395318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of proliferation in hepatocellular carcinoma with the in vivo marker 18F-fluorothymidine.
    Eckel F; Herrmann K; Schmidt S; Hillerer C; Wieder HA; Krause BJ; Schuster T; Langer R; Wester HJ; Schmid RM; Schwaiger M; Buck AK
    J Nucl Med; 2009 Sep; 50(9):1441-7. PubMed ID: 19690030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma.
    Ullrich R; Backes H; Li H; Kracht L; Miletic H; Kesper K; Neumaier B; Heiss WD; Wienhard K; Jacobs AH
    Clin Cancer Res; 2008 Apr; 14(7):2049-55. PubMed ID: 18381944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
    Chen W; Cloughesy T; Kamdar N; Satyamurthy N; Bergsneider M; Liau L; Mischel P; Czernin J; Phelps ME; Silverman DH
    J Nucl Med; 2005 Jun; 46(6):945-52. PubMed ID: 15937304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated radiochemical synthesis of pharmaceutical grade [
    Mitra A; Chakraborty A; Upadhye T; Tawate M; Lad S; Sahu S; Rajesh C; Bagul S; Pawar Y; Ray MK; Banerjee S
    J Labelled Comp Radiopharm; 2022 Jun; 65(8):206-222. PubMed ID: 35466460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.